Geisinger Health’s iShares iBoxx $ High Yield Corporate Bond ETF HYG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$84.6M Buy
1,096,915
+17,081
+2% +$1.31M 24.59% 3
2024
Q1
$83.9M Buy
1,079,834
+11,120
+1% +$859K 23.39% 3
2023
Q4
$82.7M Sell
1,068,714
-28,828
-3% -$2.15M 25.88% 2
2023
Q3
$80.9M Buy
1,097,542
+17,999
+2% +$1.34M 27.41% 2
2023
Q2
$81M Buy
1,079,543
+339,543
+46% +$25.3M 25.94% 2
2023
Q1
$55.9M Hold
740,000
13.57% 3
2022
Q4
$54.5M Buy
+740,000
New +$54.6M 13.22% 4

Other funds holding HYG

Geisinger Health's HYG Position: Q2 2024 in Review

Geisinger Health increased its iShares iBoxx $ High Yield Corporate Bond ETF (HYG) stake by 1.6% in Q2 2024, buying an estimated $1.31M and bringing the position to 1,096,915 shares worth $84.6M. The position accounts for 24.59% of the portfolio, ranked #3.

Geisinger Health first reported a position in HYG in Q4 2022 and has held it in 7 quarters since. 893 funds tracked by Wall St. Rank hold HYG as of Q2 2024.

  • Geisinger Health held 1,096,915 shares of iShares iBoxx $ High Yield Corporate Bond ETF worth $84.6M as of Q2 2024.
  • Geisinger Health bought 17,081 iShares iBoxx $ High Yield Corporate Bond ETF shares in Q2 2024, an estimated $1.31M.
  • iShares iBoxx $ High Yield Corporate Bond ETF made up 24.59% of Geisinger Health's portfolio in Q2 2024, its #3 holding.
  • Geisinger Health first reported a position in iShares iBoxx $ High Yield Corporate Bond ETF in Q4 2022 and has held it in 7 quarters since.
  • 893 funds tracked by Wall St. Rank held iShares iBoxx $ High Yield Corporate Bond ETF as of Q2 2024.

Based on Geisinger Health's 13F filing for Q2 2024, filed 14 Aug 2024.